Boston Scientific said a cyberattack disrupted parts of its global operations, according to BleepingComputer, which cited the company’s disclosure and a filing with the U.S. Securities and Exchange Commission. The medical technology company detected the incident on August 25. In a disclosure reported August 26, Boston Scientific said the attack caused a network outage that affected access to certain operating systems and business applications. That included systems used to process and ship customer orders. According to BleepingComputer, Boston Scientific activated its incident response procedures after identifying the intrusion and brought in outside cybersecurity experts to help investigate the impact and support containment work. The company said it is still working to restore affected functions and system access. The restoration timeline is not yet known. BleepingComputer reports that Boston Scientific said the incident has caused, and is expected to continue causing, disruptions and limits on access to some information systems and business applications supporting parts of its operations. The disclosure leaves several core questions unanswered. The company did not describe the type of cyberattack, name an attacker, explain the initial access method, or say whether data was exposed or stolen, according to BleepingComputer. The outlet also said it had not found a ransomware or data-extortion group publicly claiming responsibility for the incident at publication time. Boston Scientific is a Massachusetts-based medical device company that develops and manufactures products used in minimally invasive procedures, including stents, catheters, pacemakers, defibrillators and endoscopes. BleepingComputer reports the company has 59,000 employees, 13 manufacturing facilities, operations in 127 countries and more than $20 billion in annual revenue in 2025. The immediate operational issue is not just an internal IT outage. The company specifically tied the incident to order processing and shipping, which are customer-facing functions. For a global medical device manufacturer, system availability can become a business continuity issue even before any confirmed data-loss or ransomware claim emerges. Boston Scientific said its investigation is continuing and that it is still determining the nature, scope, and operational or financial consequences of the incident, according to BleepingComputer. Until the company provides more detail, the attack should be treated as a confirmed disruption with unresolved questions around cause, duration and downstream impact. Who benefits: Incident response firms and cybersecurity vendors benefit when large manufacturers accelerate containment and recovery work after operational disruption. The provided material does not identify the external experts Boston Scientific hired. Who's exposed: Boston Scientific is exposed to continued operational limits until affected systems are restored. Customers relying on order processing and shipments may also face disruption, though the sources do not quantify any delivery impact.